# Bioreliance Ltd. – FDA Inspection, Sep 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/a56f5793-c36b-4041-8038-c123cd545822
Source feed: FDA_Inspections

> FDA inspection 1026860 of Bioreliance Ltd., September 22, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026860
- Company Name: Bioreliance Ltd.
- Inspection Date: 2017-09-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1288500 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/e0050eb3-232d-48bc-a614-c2fa80560997)
- FDA Inspection 1225550 - 2023-11-07
- FDA Inspection 1202961 - 2021-03-17
- [FDA Inspection 1108960 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/c26c2b64-49cf-4023-81ce-8b8422935fd5)
- [FDA Inspection 1093195 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/6d908b43-3b15-436a-839a-aaef7318e1d3)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/carla-j-lundi/a10ed698-54fe-4635-a766-8c31f501dfb2)
- [Company Rep](https://www.keypedia.com/people/xiaoping-guan/191018c9-9f60-4db0-a9eb-48314b53e515)

Company: https://www.keypedia.com/companies/bioreliance-ltd/fec1a160-db6a-4ebc-9632-aa6e2996e17e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
